LIN Personal

Dr. Petra Henrich-Noack

Referentin der Geschäftsführung


Leibniz-Institut für Neurobiologie
Brenneckestr. 6
39118 Magdeburg
Telefon: +49 391 6263 92402

  • Publikationen


    Tawfik M, Zhang X, Grigartzik L, Heiduschka P, Hintz W, Henrich-Noack P, Van Wachem B, Sabel BA. 2021. Gene therapy with caspase-3 small interfering RNA-nanoparticles is neuroprotective after optic nerve damage. Neural Regeneration Research. 16(12):2534-2541.

    Zhang E, Osipova N, Sokolov M, Maksimenko O, Semyonkin A, Wang MH, Grigartzik L, Gelperina S, Sabel BA, Henrich-Noack P. 2021. Exploring the systemic delivery of a poorly water-soluble model drug to the retina using PLGA nanoparticles. European Journal of Pharmaceutical Sciences. 164:Article 105905.

    Zhukova V, Osipova N, Semyonkin A, Malinovskaya J, Melnikov P, Valikhov M, Porozov Y, Solovev Y, Kuliaev P, Zhang E, et al. 2021. Fluorescently labeled plga nanoparticles for visualization in vitro and in vivo: The importance of dye properties. Pharmaceutics. 13(8):Article 1145.

    Tawfik M, Hadlak S, Götze C, Sokolov M, Kulikov P, Kuskov A, Shtilman M, Sabel BA, Henrich-Noack P. 2021. Live In-Vivo Neuroimaging Reveals the Transport of Lipophilic Cargo Through the Blood-Retina Barrier with Modified Amphiphilic Poly-N-Vinylpyrrolidone Nanoparticles. Journal of biomedical nanotechnology. 17(5):846-858.

    Berdiaki A, Perisynaki E, Stratidakis A, Kulikov PP, Kuskov AN, Stivaktakis P, Henrich-Noack P, Luss AL, Shtilman MM, Tzanakakis GN, et al. 2020. Assessment of Amphiphilic Poly- N-vinylpyrrolidone Nanoparticles' Biocompatibility with Endothelial Cells in Vitro and Delivery of an Anti-Inflammatory Drug. Molecular Pharmaceutics. 17(11):4212-4225.

    Zhang E, Zhukova V, Semyonkin A, Osipova N, Malinovskaya Y, Maksimenko O, Chernikov V, Sokolov M, Grigartzik L, Sabel BA, et al. 2020. Release kinetics of fluorescent dyes from PLGA nanoparticles in retinal blood vessels: In vivo monitoring and ex vivo localization. European Journal of Pharmaceutics and Biopharmaceutics. 150:131-142.

    Sabel BA, Thut G, Haueisen J, Henrich-Noack P, Herrmann CS, Hunold A, Kammer T, Matteo B, Sergeeva EG, Waleszczyk W, et al. 2020. Vision modulation, plasticity and restoration using non-invasive brain stimulation – An IFCN-sponsored review. Clinical Neurophysiology. 131(4):887-911.

    You Q, Sokolov M, Grigartzik L, Hintz W, Van Wachem BGM, Henrich-Noack P, Sabel BA. 2019. How Nanoparticle Physicochemical Parameters Affect Drug Delivery to Cells in the Retina via Systemic Interactions. Molecular Pharmaceutics. 16(12):5068-5075.

    Henrich-Noack P, Nikitovic D, Neagu M, Docea AO, Engin AB, Gelperina S, Shtilman M, Mitsias P, Tzanakakis G, Gozes I, et al. 2019. The blood–brain barrier and beyond: Nano-based neuropharmacology and the role of extracellular matrix. Nanomedicine: Nanotechnology, Biology, and Medicine. 17:359-379.

    You Q, Hopf T, Hintz W, Rannabauer S, Voigt N, van Wachem B, Henrich-Noack P, Sabel BA. 2019. Major effects on blood-retina barrier passage by minor alterations in design of polybutylcyanoacrylate nanoparticles. Journal of Drug Targeting. 27(3):338-346.

    Khalid MK, Asad M, Henrich-Noack P, Sokolov M, Hintz W, Grigartzik L, Zhang E, Dityatev A, van Wachem B, Sabel BA. 2018. Evaluation of toxicity and neural uptake in vitro and in vivo of superparamagnetic iron oxide nanoparticles. International Journal of Molecular Sciences. 19(9):Article 2613.

    Chen W, Zuo H, Zhang E, Li L, Henrich-Noack P, Cooper H, Qian Y, Xu ZP. 2018. Brain Targeting Delivery Facilitated by Ligand-Functionalized Layered Double Hydroxide Nanoparticles. ACS Applied Materials and Interfaces. 10(24):20326-20333.

    Sokolov MV, Henrich-Noack P, Raynoschek C, Franzén B, Larsson O, Main M, Dabrowski M. 2018. Co-expression of β Subunits with the Voltage-Gated Sodium Channel NaV1.7: the Importance of Subunit Association and Phosphorylation and Their Effects on Channel Pharmacology and Biophysics. Journal of Molecular Neuroscience. 65(2):154-166.

    Zhang X, Zhang E, Grigartzik L, Henrich-Noack P, Hintz W, Sabel BA. 2018. Anti-apoptosis Function of PBCA Nanoparticles Containing Caspase-3 siRNA for Neuronal Protection. Chemie-Ingenieur-Technik. 90(4):451-455.

    Henrich-Noack P, Sergeeva EG, Sabel BA. 2017. Non-invasive electrical brain stimulation: From acute to late-stage treatment of central nervous system damage. Neural Regeneration Research. 12(10):1590-1594.

    Engin AB, Nikitovic D, Neagu M, Henrich-Noack P, Docea AO, Shtilman MI, Golokhvast K, Tsatsakis AM. 2017. Mechanistic understanding of nanoparticles' interactions with extracellular matrix: The cell and immune system. Particle and Fibre Toxicology. 14(1):Article 22.

    Henrich-Noack P, Sergeeva EG, Eber T, You Q, Voigt N, Köhler J, Wagner S, Lazik S, Mawrin C, Xu G, et al. 2017. Electrical brain stimulation induces dendritic stripping but improves survival of silent neurons after optic nerve damage. Scientific Reports. 7(1):Article 627.

    Sayapina NV, Batalova TA, Sergievich AA, Shtarberg MA, Borodin EA, Khoroshikh PP, Chaika VV, Kodintsev VV, Vedyagin AA, Mishakov IV, et al. 2017. Oral application of carbon nanofibers in rats increases blood concentration of IL6 and IL10 and decreases locomotor activity. Environmental Toxicology and Pharmacology. 50:183-191.

    Chamoun M, Sergeeva EG, Henrich-Noack P, Jia S, Grigartzik L, Ma J, You Q, Huppé-Gourgues F, Sabel BA, Vaucher E. 2017. Cholinergic Potentiation of Restoration of Visual Function after Optic Nerve Damage in Rats. Neural Plasticity. 2017:Article 6928489.

    Hall AM, Hemmer R, Spaulding R, Wetzel HN, Curcio J, Sabel BA, Henrich-Noack P, Pixley S, Hopkins T, Boyce RL, et al. 2016. Cytotoxicity and apoptotic gene expression in an in vitro model of the blood–brain barrier following exposure to poly(butylcyanoacrylate) nanoparticles. Journal of Drug Targeting. 24(7):635-644.

    Sergeeva EG, Bola M, Wagner S, Lazik S, Voigt N, Mawrin C, Gorkin AG, Waleszczyk WJ, Sabel BA, Henrich-Noack P. 2015. Repetitive transcorneal alternating current stimulation reduces brain idling state after long-term vision loss. Brain Stimulation. 8(6):1065-1073.

    Sergeeva EG, Henrich-Noack P, Gorkin AG, Sabel BA. 2015. Preclinical model of transcorneal alternating current stimulation in freely moving rats. Restorative Neurology and Neuroscience. 33(5):761-769.

    Hopf T, Kockentiedt S, Hintz W, Henrich-Noack P, Tomas J, Sabel B. 2015. Development and characterization of surface modified nanoparticle formulations in terms of size and surface properties. Paper presented at 8th International Conference for Conveying and Handling of Particulate Solids, CHoPS 2015, Tel Aviv, Israel.

    Sergeeva EG, Henrich-Noack P, Bola M, Sabel BA. 2014. Brain-state-dependent non-invasive brain stimulation and functional priming: A hypothesis. Frontiers in Human Neuroscience. 8(November):Article 899.

    Henrich-Noack P. 2014. Please keep calm: Investigating hippocampal function without stress. Frontiers in Behavioral Neuroscience. 8(OCT):1-2.

    Voigt N, Henrich-Noack P, Kockentiedt S, Hintz W, Tomas J, Sabel BA. 2014. Toxicity of polymeric nanoparticles in vivo and in vitro. Journal of Nanoparticle Research. 16(6):Article 2379.

    Voigt N, Henrich-Noack P, Kockentiedt S, Hintz W, Tomas J, Sabel BA. 2014. Surfactants, not size or zeta-potential influence blood-brain barrier passage of polymeric nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics. 87(1):19-29.

    Yang H, Shi O, Jin Y, Henrich-Noack P, Qiao H, Cai C, Tao H, Tian X. 2014. Functional protection of learning and memory abilities in rats with vascular dementia. Restorative Neurology and Neuroscience. 32(5):689-700.

    Henrich-Noack P, Lazik S, Sergeeva E, Wagner S, Voigt N, Prilloff S, Fedorov A, Sabel BA. 2013. Transcorneal alternating current stimulation after severe axon damage in rats results in " long-term silent survivor" neurons. Brain Research Bulletin. 95:7-14.

    Henrich-Noack P, Voigt N, Prilloff S, Fedorov A, Sabel BA. 2013. Transcorneal electrical stimulation alters morphology and survival of retinal ganglion cells after optic nerve damage. Neuroscience Letters. 543:1-6.

    Bola M, Prilloff S, Matzke S, Henrich-Noack P. 2013. Brain restoration as an emerging field in neurology and neuroscience. Restorative Neurology and Neuroscience. 31(6):669-679.

    Sergeeva EG, Fedorov AB, Henrich-Noack P, Sabel BA. 2012. Transcorneal alternating current stimulation induces EEG "aftereffects" only in rats with an intact visual system but not after severe optic nerve damage. Journal of Neurophysiology. 108(9):2494-2500.

    Henrich-Noack P, Prilloff S, Voigt N, Jin J, Hintz W, Tomas J, Sabel BA. 2012. In vivo visualisation of nanoparticle entry into central nervous system tissue. Archives of Toxicology. 86(7):1099-1105.

    Prilloff S, Henrich-Noack P, Sabel BA. 2012. Recovery of axonal transport after partial optic nerve damage is associated with secondary retinal ganglion cell death in vivo. Investigative Ophthalmology and Visual Science. 53(3):1460-1466.

    Henrich-Noack P, Krautwald K, Reymann KG, Wetzel W. 2011. Effects of transient global ischaemia on freezing behaviour and activity in a context-dependent fear conditioning task - Implications for memory investigations. Brain Research Bulletin. 85(6):346-353.

    Sabel BA, Henrich-Noack P, Fedorov A, Gall C. 2011. Vision restoration after brain and retina damage: The "residual vision activation theory". In Progress in Brain Research. Elsevier. pp. 199-262. (Progress in Brain Research).

    Prilloff S, Henrich-Noack P, Kropf S, Sabel BA. 2010. Experience-dependent plasticity and vision restoration in rats after optic nerve crush. Journal of Neurotrauma. 27(12):2295-2307.

    Henrich-Noack P, Riek-Burchardt M, Reymann KG, Reiser G. 2010. Cellular expression pattern of the protease-activated receptor 4 in the hippocampus in Naïve rats and after global ischaemia. Journal of Neuroscience Research. 88(4):850-857.

    Prilloff S, Fan J, Henrich-Noack P, Sabel BA. 2010. In vivo confocal neuroimaging (ICON): Non-invasive, functional imaging of the mammalian CNS with cellular resolution. European Journal of Neuroscience. 31(3):521-528.

    Riek-Burchardt M, Kolodziej A, Henrich-Noack P, Reymann KG, Höllt V, Stumm R. 2010. Differential regulation of CXCL12 and PACAP mRNA expression after focal and global ischemia. Neuropharmacology. 58(1):199-207.

    Henrich-Noack P, Baldauf K, Reiser G, Reymann KG. 2008. Pattern of time-dependent reduction of histologically determined infarct volume after focal ischaemia in mice. Neuroscience Letters. 432(2):141-145.

    Henrich-Noack P, Gorkin AG, Reymann KG. 2007. Predictive value of changes in electroencephalogram and excitatory postsynaptic field potential for CA1 damage after global ischaemia in rats. Experimental Brain Research. 181(1):79-86.

    Baldauf K, Henrich-Noack P, Reymann KG. 2007. Detrimental effects of halothane narcosis on damage after endothelin-1-induced MCAO. Journal of Neuroscience Methods. 162(1-2):14-18.

    Riek-Burchardt M, Henrich-Noack P, Reymann KG. 2007. No improvement of functional and histological outcome after application of the metabotropic glutamate receptor 5 agonist CHPG in a model of endothelin-1-induced focal ischemia in rats. Neuroscience Research. 57(4):499-503.

    Henrich-Noack P, Striggow F, Reiser G, Reymann KG. 2006. Preconditioning with thrombin can be protective or worsen damage after endothelin-1-induced focal ischemia in rats. Journal of Neuroscience Research. 83(3):469-475.

    Henrich-Noack P, Riek-Burchardt M, Baldauf K, Reiser G, Reymann KG. 2006. Focal ischemia induces expression of protease-activated receptor1 (PAR1) and PAR3 on microglia and enhances PAR4 labeling in the penumbra. Brain Research. 1070(1):232-241.

    Pforte C, Henrich-Noack P, Baldauf K, Reymann KG. 2005. Increase in proliferation and gliogenesis but decrease of early neurogenesis in the rat forebrain shortly after transient global ischemia. Neuroscience. 136(4):1133-1146.

    Henrich-Noack P, Gorkin AG, Krautwald K, Pforte C, Schröder UH, Reymann KG. 2005. Tetanus-induced re-activation of evoked spiking in the post-ischemic dentate gyrus. Neuroscience. 133(2):571-581.

    Riek-Burchardt M, Henrich-Noack P, Metz GA, Reymann KG. 2004. Detection of chronic sensorimotor impairments in the ladder rung walking task in rats with endothelin-1-induced mild focal ischemia. Journal of Neuroscience Methods. 137(2):227-233.

    Rohatgi T, Henrich-Noack P, Sedehizade F, Goertler M, Wallesch CW, Reymann KG, Reiser G. 2004. Transient Focal Ischemia in Rat Brain Differentially Regulates mRNA Expression of Protease-Activated Receptors 1 to 4. Journal of Neuroscience Research. 75(2):273-279.

    Riek-Burchardt M, Striggow F, Henrich-Noack P, Reiser G, Reymann KG. 2002. Increase of prothrombin-mRNA after global cerebral ischemia in rats, with constant expression of protease nexin-1 and protease-activated receptors. Neuroscience Letters. 329(2):181-184.

    Striggow F, Riek-Burchardt M, Kiesel A, Schmidt W, Henrich-Noack P, Breder J, Krug M, Reymann KG, Reiser G. 2001. Four different types of protease-activated receptors are widely expressed in the brain and are up-regulated in hippocampus by severe ischemia. European Journal of Neuroscience. 14(4):595-608.

    Sabelhaus CF, Schröder UH, Breder J, Henrich-Noack P, Reymann KG. 2000. Neuroprotection against hypoxic/hypoglycaemic injury after the insult by the group III metabotropic glutamate receptor agonist (R,S)-4-phosphonophenylglycine. British Journal of Pharmacology. 131(4):655-658.

    Henrich-Noack P, Flor PJ, Sabelhaus CF, Prass K, Dirnagl U, Gasparini F, Sauter A, Rudin M, Reymann KG. 2000. Distinct influence of the group III metabotropic glutamate receptor agonist (R,S)-4-phosphonophenylglycine [(R,S)-PPG] on different forms of neuronal damage. Neuropharmacology. 39(5):911-917.

    Striggow F, Riek M, Breder J, Henrich-Noack P, Reymann KG, Reiser G. 2000. The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proceedings of the National Academy of Sciences of the United States of America. 97(5):2264-2269.

    Henrich-Noack P, Reymann KG. 1999. (1S,3R)-ACPD, a metabotropic glutamate receptor agonist, enhances damage after global ischaemia. European Journal of Pharmacology. 365(1):55-58.

    Rauca C, Henrich-Noack P, Schäfer K, Höllt V, Reymann KG. 1998. (S)-4C3HPG reduces infarct size after focal cerebral ischemia. Neuropharmacology. 37(12):1649-1652.

    Henrich-Noack P, Hatton CD, Reymann KG. 1998. The mGlu receptor ligand (S)-4C3HPG protects neurons after global ischaemia in gerbils. NeuroReport. 9(6):985-988.
Diese Seite teilen: